Charles Cherington 13D and 13G filings for BROOKLYN IMMUNO THERAPEUTICS L:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-03-16 4:30 pm Sale | 2022-03-09 | 13D | Ernexa Therapeutics Inc. ERNA | Charles Cherington | 19,711 11.400% | -1,333 (-6.33%) | Filing |
| 2021-05-13 5:00 pm Purchase | 2021-03-25 | 13D | Ernexa Therapeutics Inc. ERNA | Charles Cherington | 21,044 15.200% | 21,044 (New Position) | Filing |